No Data
No Data
Baotou Dongbao Bio-tech (300239.SZ): has cumulatively repurchased 1.24% of its shares.
On March 3, Gelonghui reported that Baotou Dongbao Bio-tech (300239.SZ) announced that as of February 28, 2025, the company has cumulatively repurchased 7,348,000 shares through a dedicated securities account for share repurchase via centralized bidding, accounting for 1.2379% of the company's current total share capital, with a highest Fill Price of 5.71 yuan/share, a lowest Fill Price of 5.27 yuan/share, and a total transaction amount of 40.1431 million yuan (excluding transaction fees).
Qingdao Gon Technology (002768.SZ): Baotou Dongbao Bio-tech has established an online + offline omni-channel sales network for its TOC-end products.
On February 20th, Gelonghui reported that Qingdao Gon Technology (002768.SZ) stated on the investor interaction platform that Baotou Dongbao Bio-tech has established an online and offline omni-channel sales network for TOC end products. In terms of online sales, it is actively expanding retail channels such as e-commerce and social platforms, opening several flagship and specialty stores on e-commerce platforms like Tmall, JD.com, and PDD Holdings, and carrying out business on Short Video and social platforms such as Douyin, Kuaishou, WeChat, and Xiaohongshu, forming a fan chain communication.
There are multiple violations in fund management, Baotou Dongbao Bio-tech has received regulatory "double letters" consecutively | Quick read announcement.
① Baotou Dongbao Bio-tech has received warning letters from the Inner Mongolia Securities Regulatory Commission and the Shenzhen Stock Exchange, which have been recorded in the integrity file of the securities and futures market; ② The company was found by the Inner Mongolia Securities Regulatory Commission during an on-site inspection to have issues such as exceeding the authorized limit for Cash management balance, purchasing investment products beyond the authorized time, and not disclosing delays in fundraising projects; ③ Since last year, due to the impact of short-term market fluctuations, the company's performance has faced a decline, with product sales and prices decreasing year on year.
Baotou Dongbao Bio-tech (300239.SZ) received a warning letter from the Inner Mongolia Securities Regulatory Bureau.
Baotou Dongbao Bio-tech (300239.SZ) announced that the company received the "On-site Inspection Report from the Inner Mongolia Securities Regulatory Bureau regarding Baotou..."
Baotou Dongbao Bio-tech (300239.SZ): A total of 0.7 million shares have been repurchased.
On February 5, 2023, Gelonghui reported that Baotou Dongbao Bio-tech (300239.SZ) announced that as of January 31, 2025, the company has repurchased a total of 700,000 shares through the dedicated securities account for share repurchase via centralized bidding, accounting for 0.1179% of the company's current total share capital, with a highest Fill Price of 5.32 yuan/share, a lowest Fill Price of 5.27 yuan/share, and a total transaction amount of 3.7028 million yuan (excluding transaction fees).
Dongbao Bio-Tech to Buy Back Shares of Up to 100 Million Yuan
Not Many Are Piling Into Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239) Stock Yet As It Plummets 30%
